Prudential Financial Inc. Sells 10,083 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Prudential Financial Inc. decreased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 12.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 68,126 shares of the company’s stock after selling 10,083 shares during the quarter. Prudential Financial Inc. owned approximately 0.05% of Henry Schein worth $5,109,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of HSIC. Olstein Capital Management L.P. raised its holdings in Henry Schein by 17.2% in the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after acquiring an additional 16,000 shares during the period. Private Management Group Inc. increased its stake in shares of Henry Schein by 5.7% in the fourth quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock worth $24,256,000 after purchasing an additional 18,882 shares during the period. Equitable Trust Co. acquired a new position in shares of Henry Schein during the 4th quarter worth about $417,000. Savant Capital LLC boosted its stake in Henry Schein by 43.9% during the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company’s stock valued at $322,000 after purchasing an additional 1,420 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in Henry Schein by 29.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company’s stock valued at $1,113,000 after buying an additional 3,650 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares of the company’s stock, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Wells Fargo & Company began coverage on Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target for the company. Barrington Research reissued an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. UBS Group dropped their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Mizuho began coverage on Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Trading Down 0.2 %

HSIC stock opened at $68.49 on Tuesday. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The business’s 50 day moving average is $74.52 and its 200-day moving average is $72.68. The firm has a market cap of $8.50 billion, a P/E ratio of 28.19, a P/E/G ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the company earned $0.66 earnings per share. Equities analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.